Reinsmoen N - Search Results

1

Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation.

Lehrich RW, Rocha PN, Reinsmoen N, Greenberg A, Butterly DW, Howell DN, Smith SR. Lehrich RW, et al. Among authors: reinsmoen n. Hum Immunol. 2005 Apr;66(4):350-8. doi: 10.1016/j.humimm.2005.01.028. Hum Immunol. 2005. PMID: 15866697

2

Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection.

Rocha PN, Butterly DW, Greenberg A, Reddan DN, Tuttle-Newhall J, Collins BH, Kuo PC, Reinsmoen N, Fields T, Howell DN, Smith SR. Rocha PN, et al. Among authors: reinsmoen n. Transplantation. 2003 May 15;75(9):1490-5. doi: 10.1097/01.TP.0000060252.57111.AC. Transplantation. 2003. PMID: 12792502

3

Cellular methods used to evaluate the immune response in transplantation.

Reinsmoen NL. Reinsmoen NL. Tissue Antigens. 2002 Apr;59(4):241-50. doi: 10.1034/j.1399-0039.2002.590401.x. Tissue Antigens. 2002. PMID: 12135422 Review.

4

CPRA for allocation of kidneys in the US: More candidates ≥98% CPRA, lower positive crossmatch rates and improved transplant rates for sensitized patients.

Baxter-Lowe LA, Kucheryavaya A, Tyan D, Reinsmoen N. Baxter-Lowe LA, et al. Among authors: reinsmoen n. Hum Immunol. 2016 May;77(5):395-402. doi: 10.1016/j.humimm.2016.03.003. Epub 2016 Mar 21. Hum Immunol. 2016. PMID: 27012168

5

Cardiac transplantation at Duke University Medical Center.

Felker GM, Hernandez AF, Rogers JG, Russell SD, Reinsmoen NL, Rosenberg P, Hata JA, Lodge AJ, Milano CA. Felker GM, et al. Clin Transpl. 2004:235-41. Clin Transpl. 2004. PMID: 16704154

6

Novel immunotherapeutic approaches to improve rates and outcomes of transplantation in sensitized renal allograft recipients.

Jordan SC, Reinsmoen N, Lai CH, Vo A. Jordan SC, et al. Among authors: reinsmoen n. Discov Med. 2012 Mar;13(70):235-45. Discov Med. 2012. PMID: 22463800 Free article. Review.

7

Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients.

Vo AA, Choi J, Cisneros K, Reinsmoen N, Haas M, Ge S, Toyoda M, Kahwaji J, Peng A, Villicana R, Jordan SC. Vo AA, et al. Among authors: reinsmoen n. Transplantation. 2014 Aug 15;98(3):312-9. doi: 10.1097/TP.0000000000000064. Transplantation. 2014. PMID: 24770617 Clinical Trial.

8

Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin.

Kahwaji J, Sinha A, Toyoda M, Ge S, Reinsmoen N, Cao K, Lai CH, Villicana R, Peng A, Jordan S, Vo A. Kahwaji J, et al. Among authors: reinsmoen n. Clin J Am Soc Nephrol. 2011 Dec;6(12):2894-900. doi: 10.2215/CJN.03710411. Clin J Am Soc Nephrol. 2011. PMID: 22157713 Free PMC article.

9

A Phase I/II Trial of the Interleukin-6 Receptor-Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients.

Vo AA, Choi J, Kim I, Louie S, Cisneros K, Kahwaji J, Toyoda M, Ge S, Haas M, Puliyanda D, Reinsmoen N, Peng A, Villicana R, Jordan SC. Vo AA, et al. Among authors: reinsmoen n. Transplantation. 2015 Nov;99(11):2356-63. doi: 10.1097/TP.0000000000000741. Transplantation. 2015. PMID: 26018350 Clinical Trial.

10

Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization.

Toyoda M, Pao A, Vo A, Lukovsky M, Radha R, Sado T, Ge S, Reinsmoen N, Chai NN, Baden L, Petrosyan A, Skinner E, Mirocha J, Jordan SC. Toyoda M, et al. Among authors: reinsmoen n. Transpl Immunol. 2010 Feb;22(3-4):121-7. doi: 10.1016/j.trim.2009.11.004. Epub 2009 Nov 26. Transpl Immunol. 2010. PMID: 19944759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters